Chinese Digital Home,
Home Networking Policies, and Industry Standard Development
With
broadband networks and related technologies maturing, and following promotion
of the government's tri-network convergence policies, digital home and home
networking development for regular households in China has been accelerating in
the period covered by the country's 11th and 12th five-year plans. Standard
alliances set up by the Chinese home electronics and IT industries, such as
IGRS and ITopHome, have gradually developed a comprehensive set of national
standards for home networking in China.
To
Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/chinese-digital-home-home-networking-policies-and-industry-standard-development
Meanwhile,
telecom operators including China Telecom and China Unicom have started to promote
smart home services targeting high-income households. This report analyzes
current digital home policies in China and the development of smart home
industry standards.
Table
of Contents
1.
Development of The Digital Home and Home Networking in China
1.1
Industry Development
1.2
Human Resources Cultivation
2.
Strategies for China\'s Digital TV and Digital Home Industries in the 12th
Five-year Plan
2.1
Industry Structure
2.2
Industry Clusters
2.3
Standards Developed by China
2.4
Industry Cooperation
2.5
Trial Projects
3.
Standard Development in China\'s Home Networking Industry
3.1
IGRS
3.1.1
IGRS Smart Home Solutions
3.2
ITopHome
3.3.
WAPI
3.3.1
Current Market Status of the WAPI Standard
4.
Conclusion
Appendix
Table
1 Digital Home Technology Standards Announced by China
Table
2 Digital Home Technology Standards Currently Being Developed by
China
Figure
1 Scale of China\'s Digital Home Industry, 2008 - 2015
Figure
2 The Digital Home in China\'s 12th Five-year Plan
Figure
3 Government Agencies Involved in Digital Home Development
Figure
4 IGRS Smart Home Solutions
Figure
5 Key Members of the ITopHome Alliance
Latest Reports:
Hysterectomy
Alternatives Market - Global Industry Analysis, Size, Share, Growth, Trends and
Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/hysterectomy-alternatives-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Hysterectomy
is the process where complete or partial uterus is removed from the women’s body
by the gynecologist. In complete uterus removal, fundus, cervix and body of the
uterus are removed whereas in partial only body of the uterus is
excised.Hysterectomy is performed when a women is suffering from fibroids,
uterine prolapse, endometriosis, chronic pelvic pain, vaginal bleeding and
cancer of uterus, ovaries and cervix. It has been observed in U.S. that 1 out
of 3 women are undergoing hysterectomy annually. Hysterectomy has various
issues such as hormonal imbalance, inability to conceive and disappearance of
menstruation. To overcome these problems various alternative methods are
currently being adopted by the gynecologist. These alternatives include
myomectomy, uterine artery embolization (UAE), hysteroscopy, endometrial
ablation and hormonal treatments.
Myomectomy
is the process of removal of fibroids without altering or removing any part of
the uterus. Uterine artery embolization is the process of injecting small
particles such as PVA (poly vinyl alcohol) in the uterus which would stop the supply
of blood to the fibroids and thus stops its growth. In hysteroscopy, a small
thin instrument is inserted in the uterus through vagina to carve out the
fibroids. With the help medical management various drugs are prescribed and
device is implanted to treat different uterine problems. These drugs include
Mortin and oral contraceptives whereas devices include intrauterine devices. In
endometrial ablation, with the use of laser light infected cells of uterus are
killed and hence relieves from infection and pain while in hormonal treatment,
various hormones are injected in the body to inhibit the actions of the
infected cell.
Incretion Drugs Market - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/incretion-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Incretion
is a process of internal secretion of hormone through endocrine glands. These
hormones control the major internal body functions such as digestive activities
and movement. Sometimes these hormones are not secreted in an appropriate
amount to control internal body functions. When such situation arises, a
patient is advised for intake of incretion drugs. These incretion drugs
stimulate secretion of various endocrine hormones as per the body requirement.
Prescription
of an incretion drug varies as per the disease condition. A patient may suffer
from endocrinal disorders such as diabetes; thyroid and infertility for which
incretion drugs could be prescribed. In addition, these drugs could also be
prescribed when pituitary and adrenal glands fail to secrete hormones in
appropriate amount. Various incretion drugs include Orinase (tolbutamide),
Amaryl (gimepiride), Glucotrol XL (glipizide), Glucotrol (glipizide), Micronase
(glyburide), DiaBeta (glyburide), Glynase PresTab (glyburide, micronized),
Prandin (repaglinide) and Starlix (nateglinide). Other incretion drugs are
Januvia, Onglyza, Tradjenta, Glucovance, Metaglip, ActoPlus Met, Avandamet,
Duetact, Avandryl, PrandiMet, Janumet, PrandiMet, ActoPlus Met XR and
Kombiglyze XR.
About Us
MarketResearchReports.Biz is the most comprehensive
collection of market research reports. MarketResearchReports.Biz services are specially
designed to save time and money for our clients. We are a one stop solution for
all your research needs, our main offerings are syndicated research reports,
custom research, subscription access and consulting services. We serve all
sizes and types of companies spanning across various industries.
Contact
M/s
Sheela
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
– Canada Toll Free: 866-997-4948
No comments:
Post a Comment